Protective Effect of 25Mg-Porphyrin-Fullerene Nanoparticles on Oxygen-Glucose Deprivation/Reperfusion Injury in PC12 Cells

  • Peivand Ghasemzadeh Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran.
  • Seyed Mahdi Rezayat Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran. AND School of Advanced Science and Technology in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Sharareh Adeli Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Nahid Rahbar-Roshandel Mail Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
25Mg magnetic isotope effect, 25MgPMC16 nanoparticles, ATP, Oxygen-glucose deprivation/reperfusion, PC12 cell line


We investigated the effects of 25Mg-Porphyrin-Fullerene nanoparticles, (25MgPMC16) smart ferroporphyrin nanoparticles, on PC12 cells exposed to oxygen-glucose deprivation/reperfusion. In order to explore its effect on cells under oxygen-glucose deprivation conditions, the cultures were pretreated with 25MgPMC16 24 hours prior to oxygen-glucose deprivation/reperfusion. To initiate the oxygen-glucose deprivation/reperfusion, the cell culture medium was replaced with a glucose-free medium and the cells were transferred to a humidified incubation chamber in a mixture of 95% N2 and 5% CO2 at 37° C for 30, 60 and 120 min. Cell viability was assessed by MTT assay. Exposure of PC12 cells to 30, 60 and 120 min oxygen-glucose deprivation significantly decreased the cell viability. Pretreatment of the cultures with 25MgPMC16 significantly increased cell viability in a concentration-dependent manner. Pretreatment, the cultures with MK-801 (10 µM), a non-competitive NMDA antagonist, has attenuated the cell death after 30 min oxygen-glucose deprivation. We concluded that 25MgPMC16 could protect PC12 cells against oxygen-glucose deprivation/reperfusion-induced cell injury in a concentration-dependent manner. That could be due to the effect of 25MgPMC16 on ATP synthesis and the antioxidant effects of its components.


Szydlowska K, Tymianski M. Calcium, ischemia and excitotoxicity. Cell Calcium 2010;47:122-9.

Fujimoto S, Katsuki H, Kume T, Kaneko S, Akaike A.Mechanisms of oxygen glucose deprivation-induced glutamate release from cerebrocortical slice cultures. Neurosci Res 2004;50:179-87.

Arundine M, Tymianski M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 2003;34:325-37.

Danbolt NC. Glutamate uptake. Prog Neurobiol 2001;65:1-105.

Harukuni I, Bhardwaj A. Mechanisms of Brain Injury after Global Cerebral Ischemia. Neurol Clin 2006;24:1-21.

Jekabsons MB, Nicholls DG. In Situ Respiration and Bioenergetic Status of Mitochondria in Primary Cerebellar Granule Neuronal Cultures Exposed Continuously to Glutamate. J Biol Chem 2004;279:32989-3000.

Greenwood SM, Connolly CN. Dendritic and mitochondrial changes during glutamate excitotoxicity. Neuropharmacology 2007;53:891-8.

Zhang Y, Huang Z, Yu L, Zhang L. Protective Effects of Tetramethylpyrazine on Glutamate-Induced Neurotoxicity in Mice. JBBS 2012;2:326-32.

Tavakoli-Far B, Rahbar-Roshandel N, Rahimi- Moghaddam P, Mahmoudian M. Neuroprotective effects of mebudipine and dibudipine on cerebral oxygen-glucose deprivation/reperfusion injury. Eur J harmacol


Sen AP, Gulati A. Use of Magnesium in Traumatic Brain Injury. Neurotherapeutics 2010;7:91-9.

Bleich S, Römer K, Wiltfang J, Komhuber J. Glutamate and the glutamate receptor system: a target for drug action. Int J Geriatr Psychiatry 2003;18:S33-40.

Geddes JW. Sullivan PG. Special Issue: Mitochondria and neurodegeneration. Exp Neurol 2009;218:169-70.

Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004;287:C817-33.

Nicotera P, Orrenius S. The role of calcium in apoptosis.Cell Calcium 1998;23:173-80.

Schauwecker PE. Neuroprotection by glutamate receptor antagonists against seizure-induced excitotoxic cell death in the aging brain. Exp Neurol 2010;224:207-18.

Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 2010;460:525-2.

Moreira PI, Zhu X, Wang X, Lee GH, Nunomura A, Petersen RB, et al. Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 2010;1802:212-20.

Rezayat SM, Boushehri SV, Salmanian B, Omidvari AH, Tarighat S, Esmaeili S, et al. The porphyrin-fullerene nanoparticles to promote the ATP overproduction in myocardium: 25Mg2+-magnetic isotope effect. Eur J Med Chem 2009;44:1554-69.

Shetab Boushehri SV, Amiri S, Rezayat SM, Sarkar S.

Preventive effect of 25Mg-PMC16 Nanoparticles on Cytotoxicities of Energy Metabolism Inhibitors in Isolated Lymphocytes of Rat Blood. (Accessed May 20, 2016, at

Hosseini A, Sharifzadeh M, Rezayat SM, Hassanzadeh G, Hassani S, Baeeri M, et al. Benefit of magnesium-25

carrying porphyrin-fullerene nanoparticles in experimental diabetic neuropathy. Int J Nanomedicine 2010;5:517-23.

Garnier Y, Middelanis J, Jensen A, Berger R.Neuroprotective effects of magnesium on metabolic disturbances in fetal hippocampal slices after oxygen- glucose deprivation: mediation by nitric oxide system. J Soc Gynecol Investig 2002;9:86-92.

Kang SW, Choi SK, Park E, Chae SJ, Choi S, Jin Joo H, et al. Neuroprotective effects of magnesium-sulfate on ischemic injury mediated by modulating the release of glutamate and reduced of hyperreperfusion. Brain Res


Kaptanoglu E, Beskonakli E, Okutan O, Selcuk Surucu H, Taskin Y. Effect of magnesium sulphate in experimental spinal cord injury: evaluation with ultrastructural findings and early clinical results. J Clin Neurosci 2003;10: 329-34.

Frantseva MV, Carlen PL, El-Beheiry H. A submersion method to induce hypoxic damage in organotypic hippocampal cultures. J Neurosci Methods 1999;89:25-31.

Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.

Rahbar-Roshandel N, Razavi L, Tavakoli-Far B, Mahmoudian M. Mebudipine and dibudipine protect PC12 cells against oxygen-glucose deprivation and glutamate- induced cell death. Pathophysiology 2008;15:227-31.

Shafer TJ, Atchison WD. Atchison, Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicology 1991;12:473-92.

Buchachenko AL, Kouznetsov DA, Arkhangelsky SE, eOrlova MA, Markarian AA. Spin biochemistry: magnetic 24Mg-25Mg-26Mg isotope effect in mitochondrial ADP phosphorylation. Cell Biochem Biophys 2005;43:243-51.

McIntosh TK, Vink R, Yamakami I, Faden AI. Magnesium protects against neurological deficit after brain injury. Brain Res 1989;482:252-60.

Sirin BH, Coşkun E, Yilik L, Ortaç R, Sirin H, Tetik C.Neuroprotective effects of preischemia subcutaneous magnesium sulfate in transient cerebral ischemia. Eur J Cardiothorac Surg 1998;14:82-8.

Hazell AS. Excitotoxic mechanisms in stroke: An update of concepts and treatment strategies. Neurochem Int 2007;50:941-53.

Muir KW, Lees KR, Ford I, Davis S. Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 2004;363:439-45.

Shafiee H, Mohammadi H, Rezayat SM, Hosseini A, Baeeri M, Hassani S, et al. Prevention of malathion- induced depletion of cardiac cells mitochondrial energy and free radical damage by a magnetic magnesium- carrying nanoparticle. Toxicol Mech Methods 2010;20:538-43.

Amirshahi N, Alyautdin RN, Sarkar S, Rezayat SM, Orlova MA, Trushkov IV, et al. Porphyrin-fullerene nanoparticles for treatment of hypoxic cardiopathies. Nanotechnologies 2008;3:611-21.

Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 2004;61:657-68.

Atlante A, Calissano P, Bobba A, Giannattasio S, Marra E, Passarella S.. Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett 2001;497:1-5.

Schinder AF, Olson EC, Spitzer NC, Montal M.Mitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity. J Neurosci 1996;16:6125-33.

Reynolds A, Laurie C, Mosley RL, Gendelman HE.Oxidative Stress and the Pathogenesis of Neurodegenerative Disorder. Int Rev Neurobiol 2007;82:297-325.

Moro MA, Almeida A, Bolaños JP, Lizasoain I.Mitochondrial respiratory chain and free radical generation in stroke. Free Radic Biol Med 2005;39:1291-304.

Dugan LL, Lovett EG, Quick KL, Lin TT, O'Malley KL.Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat Disord 2001;7:243-6.

Dugan LL, Gabrielsen JK, Yu SP, Lin TS, Choi.Buckminsterfullerenol Free Radical Scavengers Reduce Excitotoxic and Apoptotic Death of Cultured Cortical Neurons. Neurobiol Dis 1996;3:129-35.

Bosi S, Da Ros T, Spalluto G, Prato M. Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem 2003;38:913-23.

Shetab Boushehri SV, Ostad SN, Sarkar S, Kuznetsov DA, Buchachenko AL, Orlova MA, et al. The C60-fullerene porphyrin adducts for prevention of the doxorubicin- induced acute cardiotoxicity in rat myocardial cells. Acta Med Iran 2010;48:342-50

Kowaltowski AJ, Naia-da-Silva ES, Castilho RF, et al.Ca2+-Stimulated Mitochondrial Reactive Oxygen Species Generation and Permeability Transition Are Inhibited by Dibucaine or Mg2+. Arch Biochem Biophys 1998;359:77-81.

Szanda G, Rajki A, Gallego-Sandín S, Garcia-Sancho J, Spät A. Effect of cytosolic Mg2+ on mitochondrial Ca2+ signaling. Pflugers Arch 2009;457:941-54.

How to Cite
Ghasemzadeh P, Rezayat SM, Adeli S, Rahbar-Roshandel N. Protective Effect of 25Mg-Porphyrin-Fullerene Nanoparticles on Oxygen-Glucose Deprivation/Reperfusion Injury in PC12 Cells. Acta Med Iran. 54(8):478-484.